| Literature DB >> 34183038 |
Lal Hussain1,2,3,4, Pauline Huang3, Tony Nguyen3, Kashif J Lone2, Amjad Ali5, Muhammad Salman Khan5, Haifang Li3, Doug Young Suh6, Tim Q Duong4.
Abstract
PURPOSE: This study used machine learning classification of texture features from MRI of breast tumor and peri-tumor at multiple treatment time points in conjunction with molecular subtypes to predict eventual pathological complete response (PCR) to neoadjuvant chemotherapy. MATERIALS ANDEntities:
Keywords: Artificial intelligence; Magnetic resonance imaging; Molecular subtypes; Neoadjuvant chemotherapy; Radiomics; Texture features
Mesh:
Year: 2021 PMID: 34183038 PMCID: PMC8240261 DOI: 10.1186/s12938-021-00899-z
Source DB: PubMed Journal: Biomed Eng Online ISSN: 1475-925X Impact factor: 2.819
Molecular subtypes of breast cancer for those with PCR and the entire data ISPY-1 data set
| Characteristics | PCR dataset | I-SPY 1 available data |
|---|---|---|
| Age ± SD (years) | 48.20 ± 8.88 | 48.25 ± 8.89 |
| Caucasian | 165 (74.66%) | |
| African American | 42 (19.00%) | |
| Asian | 9 (4.07%) | |
| Native Hawaiian/Pacific Islander | 1 (0.45%) | |
| American Indian/Alaskan Native | 0 (0.00%) | |
| Multiple race | 2 (0.90%) | |
| ER | ||
| ER+ | 95 (57.23) | 125 (56.60) |
| ER− | 71 (42.77) | 94 (42.53) |
| Missing | 2 (0.90) | |
| PgR | ||
| PgR+ | 76 (45.78) | 104 (47.05) |
| PgR− | 90 (54.22) | 117 (52.94) |
| Missing | 2 (0.90) | |
| HR | ||
| HR+ | 100 (60.24) | 131 (59.28) |
| HR− | 66 (39.76) | 90 (40.72) |
| Missing | 2 (0.90) | |
| HER2 | ||
| HER2+ | 49 (29.52) | 67 (30.32) |
| HER2− | 117 (70.48) | 149 (6.74) |
| Missing | 5 (2.26) | |
| 3 level HR/HER2 | ||
| HR+/HER2− | 74 (44.57) | 96 (43.44) |
| HER2+ | 49 (29.51) | 67 (30.32) |
| Triple− | 40 (24.09) | 53 (23.99) |
| Missing | 5 (2.26) | |
ER estrogen receptor, PgR progesterone receptor, HR hormone receptor, HER2 human epidermal growth factor receptor 2, Ki67 a cellular marker for proliferation
Fig. 1Ranking parameters for a molecular subtypes, post-contrast MRI texture at b tp1, c tp2, and d tp1 + tp2
ROC metrics for predicting PCR based on molecular subtypes, MRI features at pre- and during NAC using Ensemble RUSBoosted Tree classifier
| Time point | Features type | Sens. | Spec. | PPV | NPV | Accuracy | AUC | |
|---|---|---|---|---|---|---|---|---|
| – | Molecular subtypes | 86.48 | 76.92 | 91.42 | 66.66 | 84 | 0.82 (0.66, 0.97) | 0.07 |
| Tp1 | MRI texture only | 86.48 | 84.62 | 94.12 | 68.75 | 86 | 0.88 (0.77, 1.0) | 0.03 |
| Tp2 | 97.30 | 38.46 | 81.82 | 83.33 | 82 | 0.72 (0.53, 0.91) | 0.13 | |
| Tp3 | 92.85 | 30 | 78.78 | 60 | 76 | 0.78 (0.62, 0.95) | 0.44 | |
| Tp1 + Tp2 | 1.00 | 76.92 | 92.50 | 1.00 | 84 | 0.96 (0.92, 1.0) | 0.0003 | |
| Tp1 | MRI texture + molecular subtypes | 89.18 | 92.30 | 97.06 | 75.00 | 90 | 0.86 (0.75, 0.98) | 0.005 |
| Tp2 | 89.18 | 69.23 | 89.18 | 69.23 | 84 | 0.80 (0.64, 0.96) | 0.068 | |
| Tp3 | 96.42 | 50 | 84.38 | 83.33 | 84 | 0.87 (0.74, 0.99) | 0.09 | |
| Tp1 + Tp2 | 94.59 | 92.31 | 97.22 | 85.71 | 94 | 0.98 (0.94,1.0) | 0.0003 |
The data were tumor contours based on post-contrast-enhanced MRI with morphological dilation. The numbers in parenthesis show the 95% confidence intervals
Fig. 2Accuracy for MRI texture of tp1 + tp2 data + molecular subtypes at different dilation voxel diameters
Fig. 3Accuracy for MRI texture analysis of tp1 + tp2 data + molecular subtypes for using image data of post-contrast MRI, subtraction of pre- and post-contrast MRI, and 5-pixel dilation of the subtracted images
ROC metrics for predicting PCR using post-contrast image, subtraction image, and subtraction image with dilation at tp1 + tp2 using Ensemble RUSBoosted Tree classifier
| Method | Sens. | Spec. | PPV | NPV | Accuracy | AUC | |
|---|---|---|---|---|---|---|---|
| Post-contrast image | 89.18 | 53.84 | 84.61 | 63.64 | 80 | 0.68 (0.48, 0.87) | 0.212 |
| Subtraction image | 89.18 | 61.54 | 86.84 | 66.66 | 82 | 0.83 (0.70, 0.97) | 0.128 |
| Subtraction + 5 pixel dilation | 94.59 | 92.31 | 97.22 | 85.71 | 94 | 0.98 (0.94, 1.0) | 0.00029 |
The numbers in parenthesis show the 95% confidence intervals
MRI texture analysis using combined tp1 + tp2 MRI data and molecular subtypes using different machine learning classifiers
| Method | Sens. | Spec. | PPV | NPV | Accuracy | AUC | |
|---|---|---|---|---|---|---|---|
| Rusboosted Tree | 94.59 | 92.31 | 97.22 | 85.71 | 94 | 0.98 (0.94, 1.0) | 0.00029 |
| Decision Tree | 1.00 | 0 | 74.00 | NA | 90 | 0.92 (0.81, 1.0) | 0.00459 |
| SVM coarse Gaussian | 94.59 | 0 | 72.92 | 0 | 74 | 0.72 (0.55, 0.88) | 0.5738 |
| Kernel Naïve Bayes | 70.27 | 69.23 | 86.66 | 45.00 | 70 | 0.70 (0.55, 0.85) | 0.7925 |
| KNN | 94.59 | 0 | 72.92 | 0 | 70 | 0.60 (0.43, 0.76) | 0.7924 |
The number in parenthesis showed the 95% confidence intervals. These data were tumor contour without morphological dilation
ROC metrics for predicting PCR based on molecular subtypes, MRI features at pre- and during NAC using Ensemble RUSBoosted Tree classifier based on single view and multiview without SMOTE
| Time point | Features type | Sens. | Spec. | PPV | NPV | Accuracy | AUC |
|---|---|---|---|---|---|---|---|
| (View 1) | Molecular subtypes | 86.48 | 76.92 | 91.42 | 66.66 | 84 | 0.82 (0.66, 0.97) |
| Tp1 (view 2) | MRI texture only | 86.48 | 84.62 | 94.12 | 68.75 | 86 | 0.88 (0.77, 1.0) |
| Tp2 (view 3) | 97.30 | 38.46 | 81.82 | 83.33 | 82 | 0.72 (0.53, 0.91) | |
| Tp1 + Tp2 (view 4) | 1.00 | 76.92 | 92.50 | 1.00 | 84 | 0.96 (0.92, 1.00) | |
| Multiview | Molecular subtype and MRI texture | 97.0 | 85.0 | 94.70 | 91.70 | 94.0 | 0.96 (0.91, 1.0) |
The data were tumor contours based on post-contrast-enhanced MRI with morphological dilation. The numbers in parenthesis show the 95% confidence intervals
ROC metrics for predicting PCR based on molecular subtypes, MRI features at pre- and during NAC using Ensemble RUSBoosted Tree classifier based on single view multiview techniques with SMOTE
| Time point | Features type | Sens. | Spec. | PPV | NPV | Accuracy | AUC |
|---|---|---|---|---|---|---|---|
| (View 1) | Molecular subtypes | 65.0 | 69.0 | 85.70 | 40.90 | 66.0 | 0.69 (0.54, 0.90) |
| Tp1 (view 2) | MRI texture only | 68.0 | 100 | 100 | 52.0 | 76.0 | 0.86 (0.77, 0.96) |
| Tp2 (view 3) | 70.0 | 62.0 | 83.90 | 42.10 | 68.0 | 0.76 (0.58, 0.94) | |
| Tp1 + Tp2 (View 4) | 73.0 | 92.0 | 96.40 | 54.50 | 78.0 | 0.88 (0.78, 0.97) | |
| Multiview | Molecular subtype and MRI texture | 84.0 | 100 | 100 | 68.40 | 88.0 | 0.98 (0.94, 1.00) |
The data were tumor contours based on post-contrast-enhanced MRI with morphological dilation. The numbers in parenthesis show the 95% confidence intervals
Fig. 4Schematic diagram to show the flow of our model for prediction of PCR with single and multiview classification techniques and with and without SMOTE method
Fig. 5K-fold cross-validation procedure to avoid the model for overfitting